These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21585187)

  • 21. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
    Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
    BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume.
    Nakai Y; Tanaka N; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
    Res Rep Urol; 2017; 9():187-193. PubMed ID: 29034221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study.
    Cicione A; Cantiello F; De Nunzio C; Tubaro A; Damiano R
    Urol Oncol; 2014 Jan; 32(1):28.e27-31. PubMed ID: 23273912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing the diagnostic yield of saturation biopsy of the prostate.
    Ashley RA; Inman BA; Routh JC; Mynderse LA; Gettman MT; Blute ML
    Eur Urol; 2008 May; 53(5):976-81. PubMed ID: 17997028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies.
    Scattoni V; Roscigno M; Freschi M; Briganti A; Fantini GV; Bertini R; Salonia A; Montorsi F; Rigatti P
    Urology; 2005 Nov; 66(5):1043-7. PubMed ID: 16286121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.
    Pietzak EJ; Kabarriti AE; Mucksavage P; Bavaria T; Van Arsdalen K; Malkowicz SB; Wein AJ; Guzzo TJ
    Urology; 2014 Dec; 84(6):1442-7. PubMed ID: 25288572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy.
    Girasole CR; Cookson MS; Putzi MJ; Chang SS; Smith JA; Wells N; Oppenheimer JR; Shappell SB
    J Urol; 2006 Mar; 175(3 Pt 1):929-33; discussion 933. PubMed ID: 16469583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.
    Shah RB; Li J; Dhanani N; Mendrinos S
    Urol Oncol; 2016 Mar; 34(3):120.e1-7. PubMed ID: 26585946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate needle biopsy: 12 vs. 18 cores -- is it necessary?
    Pepe P; Aragona F
    Urol Int; 2005; 74(1):19-22. PubMed ID: 15711103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance.
    Ploussard G; Plennevaux G; Allory Y; Salomon L; Azoulay S; Vordos D; Hoznek A; Abbou CC; de la Taille A
    World J Urol; 2009 Oct; 27(5):587-92. PubMed ID: 19373471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
    Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
    Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance.
    Motamedinia P; RiChard JL; McKiernan JM; DeCastro GJ; Benson MC
    Urology; 2012 Nov; 80(5):1070-4. PubMed ID: 23107398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model.
    Abdel-Khalek M; El-Baz M; Ibrahiem el-H
    BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?
    Flury SC; Galgano MT; Mills SE; Smolkin ME; Theodorescu D
    BJU Int; 2007 Apr; 99(4):780-5. PubMed ID: 17378841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P; Aragona F
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of proliferative inflammatory atrophy finding in prostatic biopsies.
    Servian P; Celma A; Planas J; Placer J; de Torres IM; Olivan M; Morote J
    Prostate; 2015 Oct; 75(14):1669-75. PubMed ID: 26184870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.